Glucagon-like peptide-1 receptor (GLP-1) agonists, widely used to treat obesity and diabetes, may also improve key outcomes for patients with Crohns disease, according to a large real-world study presented during the 2026 Crohns & Colitis Congress, a partnership of AGA and the Crohn's & Colitis Foundation, taking place in Las Vegas
UnitedHealthcare covers certain GLP-1 receptor agonists, but approval depends on specific plan design, clinical criteria, and whether medications are prescribed for diabetes or weight management
Your gastroenterologist will create a personalized treatment plan to address both the underlying cause and your overall digestive health
With a storied history in MD/PhD training, WashU Medicine recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences
Dr Niketa is one of the best Dermatologist.I had suddenly faced problems of skin pigmentation and I visited her clinic and after That I had a long discussion with her and I got result within few months.Dr is very nice.friendly and politely .Clinic also very nice with good staff.I highly recommended her She is1 of best Dermatologists in Mumbai Expert 1 ,Thank you so much Doctor for great help
Proven Weight Loss Medications At our clinic, we offer FDA-approved GLP-1 medications, including: Semaglutide (Wegovy, Ozempic) Helps regulate appetite and improve blood sugar levels